Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells

Alessio Nencioni, Anna Garuti, Karin Schwarzenberg, Gabriella Cirmena, Giovanna Dal Bello, Ilaria Rocco, Eleonora Barbieri, Peter Brossart, Franco Patrone, Alberto Ballestrero

Research output: Contribution to journalArticle

Abstract

Proteasome inhibitors possess potent antitumor activity against a broad spectrum of human malignancies. However, the effects of these compounds on the immune system still have to be clearly determined. In the present study, we have investigated the effects of proteasome inhibitors on dendritic cells (DC), antigen-presenting cells playing a key role in the initiation of immune responses. Exposure to the proteasome inhibitors bortezomib, MG132 or epoxomicin was found to promote apoptosis of human monocyte-derived DC and to reduce the yield of viable DC when given to monocytes early during differentiation to DC. DC apoptosis via proteasome inhibition was accompanied by mitochondria disruption and subsequent activation of the caspase cascade. Up-regulation and intracellular redistribution of Bcl-2-associated X protein (Bax), a pro-apoptotic Bcl-2 family protein, were observed in DC treated with these compounds and represent a suitable mechanism leading to activation of the intrinsic apoptotic pathway. Finally, active protein synthesis was found to represent an upstream prerequisite for DC apoptosis induced by proteasome inhibitors, since the translation inhibitor cycloheximide blocked all of the steps of the observed apoptotic response. In conclusion, induction of apoptosis in DC may represent a novel mechanism by which proteasome inhibitors affect the immune response at the antigen-presenting cell level.

Original languageEnglish
Pages (from-to)681-689
Number of pages9
JournalEuropean Journal of Immunology
Volume36
Issue number3
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Proteasome Inhibitors
Dendritic Cells
Monocytes
Apoptosis
Antigen-Presenting Cells
bcl-2-Associated X Protein
Histocompatibility Antigens Class II
Proteasome Endopeptidase Complex
Cycloheximide
Caspases
Immune System
Mitochondria
Proteins
Up-Regulation

Keywords

  • Apoptosis
  • Cancer
  • Dendritic cells
  • Proteasome

ASJC Scopus subject areas

  • Immunology

Cite this

Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. / Nencioni, Alessio; Garuti, Anna; Schwarzenberg, Karin; Cirmena, Gabriella; Dal Bello, Giovanna; Rocco, Ilaria; Barbieri, Eleonora; Brossart, Peter; Patrone, Franco; Ballestrero, Alberto.

In: European Journal of Immunology, Vol. 36, No. 3, 03.2006, p. 681-689.

Research output: Contribution to journalArticle

Nencioni, A, Garuti, A, Schwarzenberg, K, Cirmena, G, Dal Bello, G, Rocco, I, Barbieri, E, Brossart, P, Patrone, F & Ballestrero, A 2006, 'Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells', European Journal of Immunology, vol. 36, no. 3, pp. 681-689. https://doi.org/10.1002/eji.200535298
Nencioni, Alessio ; Garuti, Anna ; Schwarzenberg, Karin ; Cirmena, Gabriella ; Dal Bello, Giovanna ; Rocco, Ilaria ; Barbieri, Eleonora ; Brossart, Peter ; Patrone, Franco ; Ballestrero, Alberto. / Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. In: European Journal of Immunology. 2006 ; Vol. 36, No. 3. pp. 681-689.
@article{0a847b63f64d49af99af308ce149bfa5,
title = "Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells",
abstract = "Proteasome inhibitors possess potent antitumor activity against a broad spectrum of human malignancies. However, the effects of these compounds on the immune system still have to be clearly determined. In the present study, we have investigated the effects of proteasome inhibitors on dendritic cells (DC), antigen-presenting cells playing a key role in the initiation of immune responses. Exposure to the proteasome inhibitors bortezomib, MG132 or epoxomicin was found to promote apoptosis of human monocyte-derived DC and to reduce the yield of viable DC when given to monocytes early during differentiation to DC. DC apoptosis via proteasome inhibition was accompanied by mitochondria disruption and subsequent activation of the caspase cascade. Up-regulation and intracellular redistribution of Bcl-2-associated X protein (Bax), a pro-apoptotic Bcl-2 family protein, were observed in DC treated with these compounds and represent a suitable mechanism leading to activation of the intrinsic apoptotic pathway. Finally, active protein synthesis was found to represent an upstream prerequisite for DC apoptosis induced by proteasome inhibitors, since the translation inhibitor cycloheximide blocked all of the steps of the observed apoptotic response. In conclusion, induction of apoptosis in DC may represent a novel mechanism by which proteasome inhibitors affect the immune response at the antigen-presenting cell level.",
keywords = "Apoptosis, Cancer, Dendritic cells, Proteasome",
author = "Alessio Nencioni and Anna Garuti and Karin Schwarzenberg and Gabriella Cirmena and {Dal Bello}, Giovanna and Ilaria Rocco and Eleonora Barbieri and Peter Brossart and Franco Patrone and Alberto Ballestrero",
year = "2006",
month = "3",
doi = "10.1002/eji.200535298",
language = "English",
volume = "36",
pages = "681--689",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "wiley",
number = "3",

}

TY - JOUR

T1 - Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells

AU - Nencioni, Alessio

AU - Garuti, Anna

AU - Schwarzenberg, Karin

AU - Cirmena, Gabriella

AU - Dal Bello, Giovanna

AU - Rocco, Ilaria

AU - Barbieri, Eleonora

AU - Brossart, Peter

AU - Patrone, Franco

AU - Ballestrero, Alberto

PY - 2006/3

Y1 - 2006/3

N2 - Proteasome inhibitors possess potent antitumor activity against a broad spectrum of human malignancies. However, the effects of these compounds on the immune system still have to be clearly determined. In the present study, we have investigated the effects of proteasome inhibitors on dendritic cells (DC), antigen-presenting cells playing a key role in the initiation of immune responses. Exposure to the proteasome inhibitors bortezomib, MG132 or epoxomicin was found to promote apoptosis of human monocyte-derived DC and to reduce the yield of viable DC when given to monocytes early during differentiation to DC. DC apoptosis via proteasome inhibition was accompanied by mitochondria disruption and subsequent activation of the caspase cascade. Up-regulation and intracellular redistribution of Bcl-2-associated X protein (Bax), a pro-apoptotic Bcl-2 family protein, were observed in DC treated with these compounds and represent a suitable mechanism leading to activation of the intrinsic apoptotic pathway. Finally, active protein synthesis was found to represent an upstream prerequisite for DC apoptosis induced by proteasome inhibitors, since the translation inhibitor cycloheximide blocked all of the steps of the observed apoptotic response. In conclusion, induction of apoptosis in DC may represent a novel mechanism by which proteasome inhibitors affect the immune response at the antigen-presenting cell level.

AB - Proteasome inhibitors possess potent antitumor activity against a broad spectrum of human malignancies. However, the effects of these compounds on the immune system still have to be clearly determined. In the present study, we have investigated the effects of proteasome inhibitors on dendritic cells (DC), antigen-presenting cells playing a key role in the initiation of immune responses. Exposure to the proteasome inhibitors bortezomib, MG132 or epoxomicin was found to promote apoptosis of human monocyte-derived DC and to reduce the yield of viable DC when given to monocytes early during differentiation to DC. DC apoptosis via proteasome inhibition was accompanied by mitochondria disruption and subsequent activation of the caspase cascade. Up-regulation and intracellular redistribution of Bcl-2-associated X protein (Bax), a pro-apoptotic Bcl-2 family protein, were observed in DC treated with these compounds and represent a suitable mechanism leading to activation of the intrinsic apoptotic pathway. Finally, active protein synthesis was found to represent an upstream prerequisite for DC apoptosis induced by proteasome inhibitors, since the translation inhibitor cycloheximide blocked all of the steps of the observed apoptotic response. In conclusion, induction of apoptosis in DC may represent a novel mechanism by which proteasome inhibitors affect the immune response at the antigen-presenting cell level.

KW - Apoptosis

KW - Cancer

KW - Dendritic cells

KW - Proteasome

UR - http://www.scopus.com/inward/record.url?scp=33644958956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644958956&partnerID=8YFLogxK

U2 - 10.1002/eji.200535298

DO - 10.1002/eji.200535298

M3 - Article

C2 - 16479541

AN - SCOPUS:33644958956

VL - 36

SP - 681

EP - 689

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 3

ER -